Sir, Lympro will be "changing the math" soon. I am "extremely pleased" with our "robust" pipeline. We will be dominating the Alzheimer's "space" soon by offering a "suite" of diagnostic tests.
"Non-dilutive funding" will only "unlock shareholder value" along with other "catalysts."
Any questions?
Cheers.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links